{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Manhattan",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA018132"
        ],
        "brand_name": [
          "DOPAMINE HYDROCHLORIDE"
        ],
        "generic_name": [
          "DOPAMINE HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-5820",
          "0409-9104"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "DOPAMINE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1743938",
          "1743941"
        ],
        "spl_id": [
          "7a125e39-1ecb-4c76-931a-efc9b5921d1c"
        ],
        "spl_set_id": [
          "1f306ad2-3606-4525-5a8a-ce78f426c1a2"
        ],
        "package_ndc": [
          "0409-5820-11",
          "0409-5820-01",
          "0409-9104-21",
          "0409-9104-20"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "7L3E358N9L"
        ]
      },
      "product_type": "Drugs",
      "event_id": "99824",
      "recalling_firm": "Pfizer",
      "address_1": "66 Hudson Blvd",
      "address_2": "N/A",
      "postal_code": "10001-2189",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide.",
      "recall_number": "D-0853-2026",
      "product_description": "Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.",
      "product_quantity": "N/A",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20260904",
      "center_classification_date": "20260917",
      "report_date": "20260923",
      "code_info": "Lot # NL5230, Exp Date:10/2027",
      "more_code_info": ""
    }
  ]
}